CARDIVA VASCADE MVP XL VVCS 10-12F: payments to doctors
Payments that named CARDIVA VASCADE MVP XL VVCS 10-12F as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $124K
- Providers
- 1,145
- Transactions
- 1,916
- Average per transaction
- $65
The per-transaction average — $65 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,145 providers the average total is $109, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cardiva Medical, Inc. | $115,269 | 92.7% |
| Haemonetics Corporation | $9,119 | 7.3% |